Microglia reprogram metabolic profiles for phenotype and function changes in central nervous system

Sheng Yang1, Chuan Qin1, Zi-Wei Hu1

  • 1Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

Neurobiology of Disease
|February 8, 2021
PubMed

Insights

Microglia, the immune cells of the brain, change their metabolism to fight inflammation. Reprogramming these metabolic pathways offers therapeutic potential for neurological diseases.

Area of Science:

  • Neuroimmunology
  • Cellular Metabolism

Background:

  • Microglia are key immune cells in the central nervous system.
  • Microglial activation is crucial for maintaining tissue homeostasis under stress.
  • Metabolic reprogramming significantly influences microglial immune responses.

Purpose of the Study:

  • To review microglial metabolic pathways in physiological and pathological conditions.
  • To discuss the role of metabolic reprogramming in orchestrating microglial responses to CNS pathologies.
  • To highlight the therapeutic potential of manipulating microglial metabolism for neurological diseases.

Main Methods:

  • Literature review of recent findings on microglial metabolism.
  • Analysis of metabolic pathways (glycolysis, oxidative phosphorylation, fatty acid oxidation) in different microglial states.
  • Synthesis of information on metabolic reprogramming and CNS pathologies.

Main Results:

  • Pro-inflammatory microglia rely on glycolysis for energy.
  • Anti-inflammatory microglia utilize oxidative phosphorylation and fatty acid oxidation.
  • Metabolic reprogramming is a central mechanism in microglial immune function.

Conclusions:

  • Metabolic pathways are critical regulators of microglial phenotype and function.
  • Targeting microglial metabolism holds therapeutic promise for neuroinflammation.
  • Understanding metabolic reprogramming is key to developing novel treatments for neurological disorders.

Related Concept Videos